Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 17 of 17

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Outcomes of the HORNBILL study: a Phase I/IIa trial investigating BI 764524 in patients with diabetic macular ischemia

Quan Dong Nguyen; Chirag Jhaveri; Maged S Habib; Elizabeth Pearce; Khaled Nassar; Bartlomiej Krawczyk; Martin Gliem; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):959.

ARVO Annual Meeting Abstract June 2023

The effect of Fluocinolone Acetonide Implant (Iluvien) in patients with diabetic macular edema (DME) with prior no, or sub-optimal response to Dexamethasone implants (INDEX Study)

Maged Habib; Muhammad Raza Cheema; Nikolaos Tzoumas; Ibrahim Masri; Jonathan Smith; Michael Edward Grinton; Deepali Varma; David H. W. Steel; Ajay Kotagiri

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2631.

ARVO Annual Meeting Abstract June 2023

The Phase I/IIa HORNBILL study: Investigating BI 764524 in patients with diabetic macular ischemia

Quan Dong Nguyen; Sobha Sivaprasad; Chirag Jhaveri; Maged Habib; Andrea Giani; Martin Gliem; Elizabeth Pearce

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3752.

ARVO Annual Meeting Abstract June 2021

The ILUVIEN implant in DME – are we leaving it too late?

Salman Naveed Sadiq; Maged Habib

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):110.

ARVO Annual Meeting Abstract June 2021

Real-life outcomes of dexamethasone intravitreal implant (Ozurdex) in diabetic macular oedema for treatment-naive eyes compared to anti-VEGF non-responders at three months post-treatment

Ali Essam Ghareeb; Tiffany Lau; Mila Kishikova; Ajay Kotagiri; Ibrahim Masri; Jonathan Smith; Deepali Varma; David Steel; Maged Habib

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1047.

ARVO Annual Meeting Abstract June 2021

Functional and Structural Outcomes of Patients with Diabetic macular oedema treated with multiple Ozurdex implants at 24 months – Real Life Data

Tiffany Lau; Ali Essam Ghareeb; Mila Kishikova; Ajay Kotagiri; Ibrahim Masri; Jonathan Smith; Deepali Varma; David Steel; Maged Habib

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1046.

ARVO Annual Meeting Abstract July 2019

Predictive factors for successful treatment with intravitreal ocriplasmin

Michael Grinton; Jon Rees; Maged S Habib; Roxane Hillier; Daniela Vaideanu-Collins; Smith Jonathan; David Steel

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2008.

ARVO Annual Meeting Abstract July 2019

VARIATION IN RETINAL THICKNESS IN RELATION TO CORRESPONDING CHANGES IN VISUAL ACUITY IN PATIENTS RECEIVING THE FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT FOR DIABETIC MACULAR EDEMA

Maged S Habib; Sarah Holden; Craig Currie

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2616.

ARVO Annual Meeting Abstract July 2018

Real world data on the efficacy of Fluocinolone Acetonide (ILUVIEN) in eyes with diabetic macular oedema

Haifa A Madi; Yanmei Chen; David Steel; Jonathan Smith; Teresa Sandinha; Maged S Habib

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4817.

ARVO Annual Meeting Abstract June 2017

Long-term real world outcomes in younger (under 60yrs) patients receiving anti-VEGF therapy for choridal neovascular membrane (CNVM).

Lyudmila Kishikova; Yewande Babalola; Maged S Habib; Deepali Varma; David Steel; Jonathan Smith; Maria T Sandinha; Ajay Kumar Kotagiri

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):418.

ARVO Annual Meeting Abstract June 2017

Real life long term outcomes of patients receiving intra-vitreal Aflibercept for Neo-vascular age related macular degeneration (nAMD): three years follow up.

Yewande Babalola; Lyudmila Kishikova; Maged S Habib; Deepali Varma; Jonathan Smith; Maria T Sandinha; David Steel; Ajay Kotagiri

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):423.

ARVO Annual Meeting Abstract June 2017

Assessment of Retinal Vascular Geometry (RVG) role in patients with neovascular Age Related Macular Degeneration (nAMD) participating in IVAN study.

Maged S Habib; Bashir Al Diri; Lauren Scott; Chris Rogers; Barney C Reeves; Usha Chakravarthy; David H W Steel

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1581.

ARVO Annual Meeting Abstract June 2017

Real life experience of combined fixed-dosing and Treat and Extend protocols for the treatment of Diabetic Macular Oedema (DMO) with Anti-Vascular Endothelial Growth Factors (VEGF) agents

Karim El-Assal; Alex Stubbing-Moore; Caspar Geenen; Deepali Varma; Ajay Kumar Kotagiri; Jonathan Smith; David H W Steel; Maged S Habib

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1899.

ARVO Annual Meeting Abstract June 2017

Real life experience of combined fixed-dosing and Treat and Extend protocols for intravitreal Aflibercept injections for Macular Oedema secondary to Central Retinal Vein Occlusion (CRVO)

Caspar Geenen; Karim El-Assal; David Steel; Deepali Varma; Ajay Kotagiri; Jonathan Smith; Maria T Sandinha; Maged S Habib

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3649.

ARVO Annual Meeting Abstract September 2016

Are the initial treatment results of Ranibizumab for Diabetic Macular Oedema maintained at 1 year with Pro re nata protocol? A real life experience.

Ajay Kumar Kumar Kotagiri; Maged Habib; Alex Stubbing-Moore; Dalvir Bajwa; Deepali Varma; Maria Teresa Sandinha; Jonathan Smith; David Steel

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2099.

ARVO Annual Meeting Abstract September 2016

Can Retinal Vascular Geometry predict future progression of Diabetic Retinopathy?

Maged Habib; Bashir Al-Diri; Roxanne R Crosby-Nwaobi; Sobha Sivaprasad; David Steel

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3406.

ARVO Annual Meeting Abstract June 2015

Real life clinical audit on Neo-vascular age related macular degeneration (nAMD) - comparing fixed dose Aflibercept versus PRN Ranibizumab (RBZ) over 12 months.

Romeela Layale Rana-Rahman; Ajay Kotagiri; Maged Habib; Jonothan Smith; Sandhina Teresa; David Steel; Deepali Varma; none

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4618.

Advertisement